OTHER GROUP COMPANIES
market

Board of Lupin approves acquisition of a portfolio of brands of Anglo-French Drugs & Industries

At meeting held on 17 January 2022

January 18, 2022 3:48 IST | capital market
The Board of Lupin at its meeting held on 17 January 2022 has approved the acquisition of a portfolio of brands (including all rights and interests associated with such products) of Anglo-French Drugs & Industries and its associates (subject to approval of their shareholders), to strengthen the Companys portfolio in the Vitamins, Minerals and Supplements and CNS segments.

The transaction entails a lumpsum consideration of about Rs 325 crore including working capital (normalised inventory of three months) amounting to Rs 9 crore (approx.) on a cash and debt-free basis.

Powered by Capital Market - Live News

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity